Previous studies reported that niclosamide inhibits TNF-α-induced NF-κB-dependent activity, increases reactive oxygen species (ROS) levels in AML cells, and enhances the sensitivity of lung cancer cells to ROS12,13. Here, NFKB1 is linked to lung carcinoma.